Independent journalism on sound, waves and healing · updated daily

Monday, November 16, 2026 · The Sunday letter

Two hearing aids beat one by about five points in a trial

In a 275-person randomized trial at Duke and Vanderbilt, people given two aids reported more benefit at three months, but one aid helped too and satisfaction barely differed.

Illustration for: Two hearing aids beat one by about five points in a trial

The short version

  • In a randomized trial of 275 first-time hearing aid users over 50, two aids improved a 100-point benefit score by 19.7 points and one aid by 14.4.
  • The authors say it is not clear whether that five-point gap matters in daily life, and by six months it was no longer significant.
  • At the end, about 29% of people chose to keep one aid, and most of the rest chose two.

Audiologists at Duke and Vanderbilt randomly assigned 275 adults aged 50 and over, with age-related hearing loss and almost no hearing-aid experience, to one or two prescription aids. Participants paid for the devices and services as they would in an ordinary clinic. After three months, the one-aid group’s score on a 100-point questionnaire of everyday hearing benefit had improved by 14.4 points and the two-aid group’s by 19.7, a gap of 5.3 points (95% CI 1.8 to 8.8). The trial, led by Sherri Smith, was published in JAMA Otolaryngology in August; Smith discussed it on This Week in Hearing on November 11.

The gap was the only clear win. On the trial’s registry record, satisfaction, hours of daily use and a speech-in-noise test did not differ significantly, and by six months the main score was no longer significantly different either. The authors write that it is unclear whether five points is clinically meaningful, and that the trial does not settle two aids as the standard. “If it turns out you can really only afford one, one still provided benefit,” Smith said.

When the three months ended, about 29% of people chose to keep one aid.

Audient reports on research and practice; it is not medical advice. Sound-based practices are generally low-risk, but people with epilepsy, implanted devices, hearing conditions or a history of trauma should check with a clinician first.

The Audient letter

One good read about sound, every week.

The research that held up, the practice worth trying, the place worth hearing — in one short email on Sunday evening. No hype, no supplements, unsubscribe in one click.

Weekly. Free. Your address is used for this letter and nothing else.

New here? Start with the basicsThe physics and the physiology, plainly

All explainers →